Beijing Mabworks Biotech
-
2003
Company Description
Beijing Mabworks Biotech, a gene engineering mAb company.
Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.
-
Manufacturer:
Science and Engineering -
Formed:
2003 -
Company Website:
-
Company E-mail:
-
Company Address:
BeijingChina -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits